Modera Wealth Management LLC Trims Stock Position in Colgate-Palmolive (NYSE:CL)

Modera Wealth Management LLC cut its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 7.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 112,023 shares of the company's stock after selling 8,538 shares during the period. Modera Wealth Management LLC's holdings in Colgate-Palmolive were worth $10,184,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC purchased a new position in Colgate-Palmolive during the fourth quarter worth about $26,000. Centricity Wealth Management LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $27,000. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $32,000. Bernard Wealth Management Corp. acquired a new position in Colgate-Palmolive during the fourth quarter worth $36,000. Finally, Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the third quarter worth $42,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 1.2 %

NYSE:CL traded up $1.14 during midday trading on Monday, hitting $92.31. 1,961,692 shares of the company were exchanged, compared to its average volume of 4,801,673. The company has a fifty day simple moving average of $88.74 and a 200 day simple moving average of $95.43. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a market capitalization of $74.91 billion, a PE ratio of 26.20, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the firm posted $0.87 EPS. As a group, equities analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.17%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio is currently 56.82%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CL shares. Raymond James reissued an "outperform" rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Morgan Stanley lowered their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. Barclays dropped their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a report on Friday, January 17th. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of "Hold" and a consensus target price of $101.61.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.